Literature DB >> 6682456

Respiratory syncytial virus mRNA coding assignments.

Y T Huang, G W Wertz.   

Abstract

The polypeptide coding assignments for six of the respiratory syncytial virus-specific mRNAs were determined by translation of the individual mRNAs in vitro. The coding assignments of the RNAs are as follows. RNA band 1 is complex and can be separated into at least two components on the basis of electrophoretic mobility (molecular weights [MWs] approximately equal to 0.21 X 10(6) and 0.31 X 10(6), respectively) that code for three polypeptides of 9.5, 11, and 14 kilodaltons (K). RNA 2 (MW, 0.39 X 10(6)) codes for a 34K polypeptide; RNA 3 (MW, 0.40 X 10(6)) codes for a 26K polypeptide; RNA 4 (MW, 0.47 X 10(6)) codes for a 42K polypeptide; and RNA 5 (MW, 0.74 X 10(6)) codes for a 59K polypeptide. By limited-digest peptide mapping, the 34, 26, and 42K polypeptides synthesized in vitro appeared to be unique. Additionally, peptide mapping showed that the 34, 26, and 42K polypeptides synthesized in vitro were indistinguishable from their counterparts synthesized in infected cells. Thus, the 34, 26, and 42K polypeptides coded for by mRNAs 2, 3, and 4, respectively, were identified as the respiratory syncytial virus phosphoprotein (34K), matrix protein (26K), and nucleocapsid protein (42K), respectively. RNA 5 was shown to code for a 59K polypeptide. The 59K polypeptide synthesized in vitro did not comigrate with any polypeptide specific to infected cells, suggesting that it is a candidate for co- or post-translational modification.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6682456      PMCID: PMC255175     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Phosphoproteins of vesicular stomatitis virus: identity and interconversion of phosphorylated forms.

Authors:  G M Clinton; B W Burge; A S Huang
Journal:  Virology       Date:  1979-11       Impact factor: 3.616

2.  Respiratory syncytial virus proteins.

Authors:  W H Wunner; C R Pringle
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

3.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

4.  Respiratory syncytial virus polypeptides: their location in the virion.

Authors:  M Peeples; S Levine
Journal:  Virology       Date:  1979-05       Impact factor: 3.616

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  A comparison of the polypeptides of human and bovine respiratory syncytial viruses and murine pneumonia virus.

Authors:  P Cash; W H Wunner; C R Pringle
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

7.  Polypeptides of respiratory syncytial virus.

Authors:  S Levine
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

8.  The polypeptides of human respiratory syncytial virus: products of cell-free protein synthesis and post-translational modifications.

Authors:  P Cash; C R Pringle; C M Preston
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

9.  RNase III cleaves vesicular stomatitis virus genome-length RNAs but fails to cleave viral mRNA's.

Authors:  G W Wertz; N L Davis
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

10.  The genome of respiratory syncytial virus is a negative-stranded RNA that codes for at least seven mRNA species.

Authors:  Y T Huang; G W Wertz
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

View more
  19 in total

1.  Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus.

Authors:  J A Nicholas; M A Mitchell; M E Levely; K L Rubino; J H Kinner; N K Harn; C W Smith
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

2.  Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus.

Authors:  P L Collins; Y T Huang; G W Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 3.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

4.  Sequence analysis of the respiratory syncytial virus phosphoprotein gene.

Authors:  M Satake; N Elango; S Venkatesan
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

5.  Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptides to the 10 viral genes.

Authors:  P L Collins; Y T Huang; G W Wertz
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

6.  Transcriptional mapping of human respiratory syncytial virus.

Authors:  L E Dickens; P L Collins; G W Wertz
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.

Authors:  Matthew B Elliott; Karin S Pryharski; Qingzhong Yu; Christopher L Parks; Todd S Laughlin; C Kanta Gupta; Robert A Lerch; Valerie B Randolph; Natisha A LaPierre; Kristen M Heers Dack; Gerald E Hancock
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Nucleotide sequence of the gene encoding respiratory syncytial virus matrix protein.

Authors:  M Satake; S Venkatesan
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  The envelope-associated 22K protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript.

Authors:  P L Collins; G W Wertz
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

10.  Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus.

Authors:  C D Richardson; A Berkovich; S Rozenblatt; W J Bellini
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.